NASDAQ: ATTOAttovia Therapeutics Inc Stock Ownership - Who owns Attovia Therapeutics?
Insider buying vs selling
Have Attovia Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Redmile Group LLC | 10% Owner | 2026-08-06 | 400,000 | $17.00 | $6.80MBuy |
| Frazier Life Sciences XI LP | 10% Owner | 2026-08-06 | 588,235 | $17.00 | $10.00MBuy |
| Sanofi | 10% Owner | 2026-08-06 | 300,000 | $17.00 | $5.10MBuy |
| Venbio Global Strategic Fund IV LP | 10% Owner | 2026-08-06 | 382,352 | $17.00 | $6.50MBuy |
| Goldman Sachs Group Inc | Insider | 2026-08-06 | 500,000 | $17.00 | $8.50MBuy |
| Goldman Sachs Group Inc | Insider | 2026-08-06 | 500,000 | $17.00 | $8.50MBuy |
| Goldman Sachs Group Inc 1 | Insider | 2026-08-06 | 500,000 | $17.00 | $8.50MBuy |
| Redmile Group LLC | 10% Owner | 2026-08-06 | 200,000 | $17.00 | $3.40MBuy |
| Colin Walsh | Director | 2026-08-06 | 500,000 | $17.00 | $8.50MBuy |
| Colin Walsh | Director | 2026-08-06 | 500,000 | $17.00 | $8.50MBuy |
ATTO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATTO insiders and whales buy or sell their stock.
ATTO Shareholders
What type of owners hold Attovia Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences XI LP | 13.48% | 6,154,213 | $111.82M | Insider |
| Venbio Global Strategic Fund IV LP | 9.16% | 4,181,367 | $75.98M | Insider |
| Alamar Holdco LLC | 7.07% | 3,229,278 | $58.68M | Insider |
| Colin Walsh | 6.62% | 3,020,632 | $54.88M | Insider |
| Goldman Sachs Group Inc | 6.62% | 3,020,632 | $54.88M | Insider |
| Goldman Sachs Group Inc 1 | 6.62% | 3,020,632 | $54.88M | Insider |
| Redmile Group LLC | 4.74% | 2,165,708 | $39.35M | Insider |
| Deep Track Biotechnology Master Fund Ltd | 4.29% | 1,957,138 | $35.56M | Insider |
| Sanofi | 2.37% | 1,082,855 | $19.68M | Insider |
| Attovia Therapeutics Inc | 0.73% | 333,268 | $6.06M | Insider |
ATTO vs Biotech Stocks
Attovia Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.